“…These include ten proteins (APCS, APOM, C1qA, C4BPA, CBP2, F2, FBLN1, IGKV1D-12, KLKB1, SERPINF2) that differentiate the cardioembolic vs. large-vessel stroke, six other proteins (AMBP, APOA4, FCN3, ITIH4, LBP, PF4) that differentiate the cardioembolic vs. lacunar stroke, and another six proteins (APOL1, C5, GPX3, GSN, H2AFJ, IGK) that differentiate the large-vessel vs. lacunar stroke (Table 3, Figure 3B). To the best of our knowledge, with the exception of C5, known to be associated with large-vessel stroke in a Chinese population [18], these differentiating proteins, weree not previously associated with a specific subtype of the ischemic stroke. These findings raise a possiblity that the ischemic stroke subtype-specific proteins can be exploited, most likely as a panel, in diagnosis and prognosis of outcomes, and possibly therapeutic interventions.…”